Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese The 'Critical Weight' and the 'Fictitious Height', a Possible Solution to an Unsolved Problem?

被引:14
作者
La Colla, L. [1 ]
Albertin, A. [2 ]
La Colla, G. [3 ]
机构
[1] Univ Vita Salute San Raffaele, IRCCS H San Raffaele, Sch Med, Dept Anesthesiol, I-20132 Milan, Italy
[2] IRCCS Multimed, Dept Anesthesiol, Milan, Italy
[3] Univ Modena & Reggio Emilia, Dept Anaesthesiol, Modena, Italy
关键词
Obese Patient; Pharmacokinetic Parameter; Remifentanil; Lean Body Mass; Pharmacokinetic Model;
D O I
10.2165/00003088-200948060-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:397 / 398
页数:2
相关论文
共 5 条
[1]   Caution when lean body weight is used as a size descriptor for obese subjects [J].
Green, B ;
Duffull, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) :743-744
[2]  
James W P T, 1976, RES OB REP DHSS MRC
[3]   Quantification of lean bodyweight [J].
Janmahasatian, S ;
Duffull, SB ;
Ash, S ;
Ward, LC ;
Byrne, NM ;
Green, B .
CLINICAL PHARMACOKINETICS, 2005, 44 (10) :1051-1065
[4]  
LACOLLA L, 2007, 1 WORLD C TOT INTR A
[5]   Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil .1. Model development [J].
Minto, CF ;
Schnider, TW ;
Egan, TD ;
Youngs, E ;
Lemmens, HJM ;
Gambus, PL ;
Billard, V ;
Hoke, JF ;
Moore, KHP ;
Hermann, DJ ;
Muir, KT ;
Mandema, JW ;
Shafer, SL .
ANESTHESIOLOGY, 1997, 86 (01) :10-23